These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20415767)

  • 1. Mifepristone-induced abortion and duration of third stage labour in a subsequent pregnancy.
    Miao MH; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Paediatr Perinat Epidemiol; 2010 Mar; 24(2):125-30. PubMed ID: 20415767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone-induced abortion and placental complications in subsequent pregnancy.
    Zhu QX; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Hum Reprod; 2009 Feb; 24(2):315-9. PubMed ID: 19054774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy.
    Chen A; Yuan W; Meirik O; Wang X; Wu SZ; Zhou L; Luo L; Gao E; Cheng Y
    Am J Epidemiol; 2004 Jul; 160(2):110-7. PubMed ID: 15234931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
    Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interpregnancy interval after a mifepristone-induced abortion on neonatal outcomes in subsequent pregnancy.
    Huo XX; Gao ES; Cheng YM; Luo L; Liang H; Huang GY; Miao MH; Yuan W
    Contraception; 2013 Jan; 87(1):38-44. PubMed ID: 23040132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated medical abortions and the risk of preterm birth in the subsequent pregnancy.
    Liao H; Wei Q; Duan L; Ge J; Zhou Y; Zeng W
    Arch Gynecol Obstet; 2011 Sep; 284(3):579-86. PubMed ID: 20978775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced abortion and duration of third stage labour in a subsequent pregnancy.
    Zhou W; Gao E; Che Y; Olsen J
    J Obstet Gynaecol; 1999 Jul; 19(4):349-54. PubMed ID: 15512328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous history of surgically induced abortion and complications of the third stage of labour in subsequent normal vaginal deliveries.
    Haldre K; Rahu K; Karro H; Rahu M
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):884-8. PubMed ID: 19065460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study.
    Moreau C; Kaminski M; Ancel PY; Bouyer J; Escande B; Thiriez G; Boulot P; Fresson J; Arnaud C; Subtil D; Marpeau L; Rozé JC; Maillard F; Larroque B;
    BJOG; 2005 Apr; 112(4):430-7. PubMed ID: 15777440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of early pregnancy with mifepristone in combination with gemeprost.
    Sandstrøm O; Brooks L; Schantz A; Grinsted J; Grinsted L; Jacobsen JD; Nielsen SP
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):806-9. PubMed ID: 10535346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical abortion in early pregnancy: experience in China.
    Cheng L
    Contraception; 2006 Jul; 74(1):61-5. PubMed ID: 16781263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
    Rose SB; Shand C; Simmons A
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced abortion: not an independent risk factor for pregnancy outcome, but a challenge for health counseling.
    Raatikainen K; Heiskanen N; Heinonen S
    Ann Epidemiol; 2006 Aug; 16(8):587-92. PubMed ID: 16621599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with immediate abortion complications.
    Ferris LE; McMain-Klein M; Colodny N; Fellows GF; Lamont J
    CMAJ; 1996 Jun; 154(11):1677-85. PubMed ID: 8646655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced abortion and prematurity in a subsequent pregnancy: a study from Shanghai.
    Che Y; Zhou W; Gao E; Olsen J
    J Obstet Gynaecol; 2001 May; 21(3):270-3. PubMed ID: 12521858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
    Rossi B; Creinin MD; Meyn LA
    Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.